Reaction

Infusion Site Phlebitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 226 reports · 3 co-occurring drugs

As of the last recalculation, Infusion Site Phlebitis appears in 226 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is AMIODARONE HYDROCHLORIDE (PRR 262.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amiodarone Hydrochloride	28	262.5	263.2
Bendamustine Hydrochloride	27	235.7	236.2
Iron Sucrose	9	90.5	90.6

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.